semaglutide 3mg vial Rybelsus: Dosage & Side Effects like peptide Wegovy vs Rybelsus | Semaglutide

No dedicated cardiovascular outcomes trial has been reported

Unfortunately, recent studies have found that the use of certain GLP-1 receptor agonist medications such as Ozempic, Wegovy, Rybelsus and other GLP-1 medications may be associated with an increased risk of developing non-arteritic anterior ischemic optic neuropathy or NAION

However, to avoid complications, use these medications cautiously and under the guidance of a healthcare provider

61 The (THR) -selective agonists strong ability to reduce hepatic fat and multiple atherogenic lipids (LDL cholesterol, apolipoprotein B, triglycerides, lipoprotein) suggests a possible cardiovascular benefit, which is highly desirable in the NASH population